Since its foundation, Angiolife Healthcare has focused on developing a modern product portfolio with a wide range of high quality medicines within all major therapeutic areas.
Such as cardiovascular, the central nervous system, gastrointestinal, diabetes, oncology, dermatology, respiratory, inflammatory, Gynaecology, Genito-urinary, antifungal, antiviral, endocrinology, analgesic and antibiotics.
Angiolife Healthcare long-term strategy is to expand the product portfolio for all versions of blockbusters as well as to gradually offer a broader range of niche products within more narrow disease areas or to meet the demand for regional treatment principles.
The company currently has 187 products in its portfolio whereof 160 are launched and 27 products are in development or under registration.
"We are committed to provide the highest quality health care products and Standard services consistently which satisfies our regular customers".